(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-20 View latest technical analysis
10 day averaged volume of Adaptimmune Therapeutics is 1736209
| Date | Daily Closing Price | Open | High | Low | Volume |
| 20 Tue Aug 2024 | 1.06 | 1.11 | 1.13 | 1.02 | 1.194 times |
| 19 Mon Aug 2024 | 1.08 | 1.08 | 1.09 | 1.05 | 0.655 times |
| 16 Fri Aug 2024 | 1.08 | 1.09 | 1.09 | 1.04 | 0.527 times |
| 15 Thu Aug 2024 | 1.09 | 1.08 | 1.09 | 1.05 | 0.55 times |
| 14 Wed Aug 2024 | 1.04 | 1.06 | 1.08 | 1.00 | 0.83 times |
| 13 Tue Aug 2024 | 1.05 | 1.11 | 1.15 | 1.04 | 1.134 times |
| 12 Mon Aug 2024 | 1.09 | 1.08 | 1.19 | 1.04 | 2.538 times |
| 09 Fri Aug 2024 | 0.99 | 1.01 | 1.04 | 0.97 | 0.867 times |
| 08 Thu Aug 2024 | 0.99 | 1.02 | 1.02 | 0.94 | 0.825 times |
| 07 Wed Aug 2024 | 1.01 | 1.00 | 1.06 | 1.00 | 1.05 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 1 as stoploss in an intra day buy trade for a target of 1.14. However, stock will show a bearish move below 1.
Share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Target | 0.83 |
| Downside Target | 0.87 |
| Downside Target | 0.94 |
| Downside Target | 0.98 |
| Downside Target | 1.00 |
| Downside Target | 1.02 |
| Upside Target | 1.08 |
| Upside Target | 1.13 |
| Upside Target | 1.19 |
| Upside Target | 1.34 |
| Upside Target | 1.36 |
| Upside Target | 1.42 |
| Upside Target | 1.48 |
| Upside Target | 1.55 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
| Target Type | Value |
| Downside Intraday Target | 1.01 |
| Downside Intraday Target | 0.96 |
| Upside Intraday Target | 1.12 |
| Upside Intraday Target | 1.18 |
| Upside Intraday Target | 1.07 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 20 Tue Aug 2024 | 1.06 | 1.08 | 1.13 | 1.02 | 0.331 times |
| 16 Fri Aug 2024 | 1.08 | 1.08 | 1.19 | 1.00 | 0.887 times |
| 09 Fri Aug 2024 | 0.99 | 1.04 | 1.08 | 0.94 | 0.458 times |
| 02 Fri Aug 2024 | 1.17 | 1.43 | 1.48 | 1.04 | 2.992 times |
| 26 Fri Jul 2024 | 1.39 | 1.20 | 1.42 | 1.16 | 0.976 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 20 Tue Aug 2024 | 1.06 | 1.33 | 1.36 | 0.94 | 0.939 times |
| 31 Wed Jul 2024 | 1.33 | 1.00 | 1.48 | 0.98 | 1.232 times |
| 28 Fri Jun 2024 | 0.97 | 1.10 | 1.15 | 0.83 | 0.953 times |
| 31 Fri May 2024 | 1.13 | 1.19 | 1.34 | 1.00 | 1.279 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.05 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
Adaptimmune Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Adaptimmune Therapeutics in short term but SELL signal is weak.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Adaptimmune Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.05 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.